Please login to the form below
J&J acquires oncology candidate in $1bn Aragon buy
ARN-509 is in phase II development for castration resistant prostate cancer
AstraZeneca picks location for global HQ and research base
Decides on the Cambridge Biomedical Campus in UK
Roche's Avastin gains Japanese approval for brain cancer
Marks drug's first approval to treat newly diagnosed glioblastoma
New data backs J&J’s ibrutinib efficacy in B cell cancers
Phase II results showcased at European Hematology Association meeting
Elotuzumab on track for multiple myeloma
BMS and AbbVie present phase II results at European Haematology Association meeting
Think positive: the rise of 'smart drugs'
More and more people are turning to nootropics or 'smart drugs' to enhance their cognitive ability. But what do they do, what are the risks and where do the ethical
The future of HTA harmonisation in Europe
The variety and variability of European health technology assessment criteria have created a challenging environment for pharma and a need for much greater harmonisation
PatientsLikeMe signs clinical trial deal with inVentiv
Online patient network aims to help the CRO accelerate trial recruitment
Former UK health secretary joins Bupa board
Patricia Hewitt will serve private health firm as non-executive director
Experience me: building engagement through experience
Connected brand experiences can drive social conversation and deeper engagement
Former Novartis president joins Qu Biologics
Robert Pelzer is appointed board member at immunotherapy specialists
Why does the global data warehouse approach not work?
Webinar on how to align business intelligence globally and deploy it locally
Pharmacists take tablets to keep up in new NHS
Pharmacy group Alphega to offer free devices and tailored apps to its UK members
Featured jobs
- Head of Commercial Training Strategy (m/ f)
- On application
- Marketing Manager - Pharmaceuticals, Northern UK
- Excellent Salary & Benefits
- UK Marketing Director
- 80,000 to 100,000 per annum
- Medical Writer / Editor – LONDON
- DOE
Subscribe to our email news alerts
- Celgene wins expanded EU approval for cancer drug Revlimid
- Alexion begins work on new global headquarters
- Former UK health secretary joins Bupa board
- Novartis launches European advanced breast cancer campaign
- J&J acquires oncology candidate in $1bn Aragon buy
- Men's oesophageal cancer risk "triple that of women"
PMHub
Add my companyComplete True Life
Complete True Life is a progressive new agency specializing in the validation of insights-led and generation of evidence-based real-world studies ...
Latest intelligence
- What IF (Indigenus Forum) Meeting Report
- IFs (Indigenus Forums) are a series of invite-only events hosted by Indigenus agencies that bring top thought leaders together to help solve some of our industry’s most pressing challenges. ...
- Developing multichannel capability in Pharma
- Understanding your customers' needs is only half of the multichannel challenge; you must also have the business capability to deliver on your objectives. Find out how training could give your ...
- Deal Watch table for May 2013
- Table listing all the major pharma mergers, acquisitions and collaborations in the past month...
Quick links
